• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程化细胞膜衍生纳米颗粒在免疫调节中的作用。

Engineered Cell Membrane-Derived Nanoparticles in Immune Modulation.

机构信息

Institute of Burn Research, The First Affiliated Hospital, State Key Lab of Trauma, Burn and Combined Injury, Chongqing Key Laboratory for Disease Proteomics, Third Military Medical University (Army Medical University), Chongqing, 400038, China.

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

出版信息

Adv Sci (Weinh). 2021 Dec;8(24):e2102330. doi: 10.1002/advs.202102330. Epub 2021 Oct 24.

DOI:10.1002/advs.202102330
PMID:34693653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8693058/
Abstract

Immune modulation is one of the most effective approaches in the therapy of complex diseases, including public health emergency. However, most immune therapeutics such as drugs, vaccines, and cellular therapy suffer from the limitations of poor efficacy and adverse side effects. Fortunately, cell membrane-derived nanoparticles (CMDNs) have superior compatibility with other therapeutics and offer new opportunities to push the limits of current treatments in immune modulation. As the interface between cells and outer surroundings, cell membrane contains components which instruct intercellular communication and the plasticity of cytomembrane has significantly potentiated CMDNs to leverage our immune system. Therefore, cell membranes employed in immunomodulatory CMDNs have gradually shifted from natural to engineered. In this review, unique properties of immunomodulatory CMDNs and engineering strategies of emerging CMDNs for immune modulation, with an emphasis on the design logic are summarized. Further, this review points out some pressing problems to be solved during clinical translation and put forward some suggestions on the prospect of immunoregulatory CMDNs. It is anticipated that this review can provide new insights on the design of immunoregulatory CMDNs and expand their potentiation in the precise control of the dysregulated immune system.

摘要

免疫调节是治疗复杂疾病(包括公共卫生紧急情况)的最有效方法之一。然而,大多数免疫疗法,如药物、疫苗和细胞疗法,都存在疗效差和不良反应的局限性。幸运的是,细胞膜衍生的纳米颗粒(CMDNs)与其他疗法具有更好的兼容性,并为推动当前免疫调节治疗方法的极限提供了新的机会。作为细胞与外界环境之间的界面,细胞膜包含指导细胞间通讯的成分,细胞质膜的可塑性极大地增强了 CMDNs 的能力,使其能够利用我们的免疫系统。因此,用于免疫调节的 CMNDs 的细胞膜已逐渐从天然向工程化转变。在这篇综述中,总结了免疫调节型 CMNDs 的独特性质和新兴 CMNDs 的免疫调节工程策略,重点介绍了设计逻辑。此外,本文还指出了在临床转化过程中需要解决的一些紧迫问题,并对免疫调节型 CMNDs 的前景提出了一些建议。预计这篇综述能为免疫调节型 CMNDs 的设计提供新的见解,并扩大其在调控失调免疫系统方面的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/da7a053f6c66/ADVS-8-2102330-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/ff73aecc9432/ADVS-8-2102330-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/f89a7274cbed/ADVS-8-2102330-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/e0f6295201d0/ADVS-8-2102330-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/ae20010db0f3/ADVS-8-2102330-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/5c984002d7cf/ADVS-8-2102330-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/2ffa366d2274/ADVS-8-2102330-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/2cca2b6cd7c4/ADVS-8-2102330-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/61dec60717cb/ADVS-8-2102330-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/3877114435e1/ADVS-8-2102330-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/bb8027e8099b/ADVS-8-2102330-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/bcfe14ac9071/ADVS-8-2102330-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/da7a053f6c66/ADVS-8-2102330-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/ff73aecc9432/ADVS-8-2102330-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/f89a7274cbed/ADVS-8-2102330-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/e0f6295201d0/ADVS-8-2102330-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/ae20010db0f3/ADVS-8-2102330-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/5c984002d7cf/ADVS-8-2102330-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/2ffa366d2274/ADVS-8-2102330-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/2cca2b6cd7c4/ADVS-8-2102330-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/61dec60717cb/ADVS-8-2102330-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/3877114435e1/ADVS-8-2102330-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/bb8027e8099b/ADVS-8-2102330-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/bcfe14ac9071/ADVS-8-2102330-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861f/8693058/da7a053f6c66/ADVS-8-2102330-g004.jpg

相似文献

1
Engineered Cell Membrane-Derived Nanoparticles in Immune Modulation.工程化细胞膜衍生纳米颗粒在免疫调节中的作用。
Adv Sci (Weinh). 2021 Dec;8(24):e2102330. doi: 10.1002/advs.202102330. Epub 2021 Oct 24.
2
In Situ Modification of the Tumor Cell Surface with Immunomodulating Nanoparticles for Effective Suppression of Tumor Growth in Mice.免疫调节纳米颗粒原位修饰肿瘤细胞表面有效抑制小鼠肿瘤生长
Adv Mater. 2019 Aug;31(32):e1902542. doi: 10.1002/adma.201902542. Epub 2019 Jun 11.
3
Programming Cell-Cell Interactions through Non-genetic Membrane Engineering.通过非遗传膜工程编程细胞-细胞相互作用。
Cell Chem Biol. 2018 Aug 16;25(8):931-940. doi: 10.1016/j.chembiol.2018.05.009. Epub 2018 Jun 14.
4
Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy.具有内在免疫调节作用的先进生物材料用于癌症免疫治疗
Small Methods. 2023 May;7(5):e2201404. doi: 10.1002/smtd.202201404. Epub 2023 Feb 21.
5
Non-genetic engineering of cells for drug delivery and cell-based therapy.细胞的非遗传工程用于药物输送和基于细胞的治疗。
Adv Drug Deliv Rev. 2015 Aug 30;91:125-40. doi: 10.1016/j.addr.2014.12.003. Epub 2014 Dec 24.
6
Engineering Nanoparticles toward the Modulation of Emerging Cancer Immunotherapy.工程纳米颗粒以调节新兴的癌症免疫疗法。
Adv Healthc Mater. 2021 Mar;10(5):e2000845. doi: 10.1002/adhm.202000845. Epub 2020 Aug 12.
7
Immunoengineering the next generation of arthritis therapies.免疫工程学:下一代关节炎治疗策略
Acta Biomater. 2021 Oct 1;133:74-86. doi: 10.1016/j.actbio.2021.03.062. Epub 2021 Apr 3.
8
Extracellular Vesicles for Immunomodulation in Tissue Regeneration.用于组织再生免疫调节的细胞外囊泡
Tissue Eng Part C Methods. 2022 Aug;28(8):393-404. doi: 10.1089/ten.tec.2022.0000059. Epub 2022 Jul 19.
9
Role of Immune Therapies for Myeloma.免疫疗法在骨髓瘤中的作用。
J Natl Compr Canc Netw. 2015 Nov;13(11):1440-7. doi: 10.6004/jnccn.2015.0168.
10
Nano-enabled immunomodulation.纳米介导的免疫调节。
Nat Nanotechnol. 2021 Jan;16(1):1. doi: 10.1038/s41565-020-00842-8.

引用本文的文献

1
Exploiting the Warburg Effect: Co-Delivery of Metformin and FOXK2 siRNA for Ovarian Cancer Therapy.利用瓦伯格效应:二甲双胍与FOXK2小干扰RNA共递送用于卵巢癌治疗
Small Sci. 2024 Jan 29;4(3):2300192. doi: 10.1002/smsc.202300192. eCollection 2024 Mar.
2
Genetically engineered cellular nanoparticles loaded with curcuminoids for cancer immunotherapy.载有姜黄素的基因工程细胞纳米颗粒用于癌症免疫治疗。
Theranostics. 2024 Oct 7;14(16):6409-6425. doi: 10.7150/thno.99033. eCollection 2024.
3
A Genetically Engineered Biomimetic Nanodecoy for the Treatment of Liver Fibrosis.

本文引用的文献

1
Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy.基因工程改造的细胞囊泡,其表达CD64作为用于癌症免疫治疗的检查点抗体载体。
Theranostics. 2021 Apr 7;11(12):6033-6043. doi: 10.7150/thno.48868. eCollection 2021.
2
Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology.生物工程菌来源的外膜囊泡作为一种多功能抗原展示平台,通过 Plug-and-Display 技术用于肿瘤疫苗接种。
Nat Commun. 2021 Apr 6;12(1):2041. doi: 10.1038/s41467-021-22308-8.
3
Nanotechnology approaches for global infectious diseases.
一种用于治疗肝纤维化的基因工程仿生纳米诱饵。
Adv Sci (Weinh). 2024 Oct;11(40):e2405026. doi: 10.1002/advs.202405026. Epub 2024 Aug 29.
4
Functionally Designed Nanovaccines against SARS-CoV-2 and Its Variants.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其变体的功能设计纳米疫苗。
Vaccines (Basel). 2024 Jul 12;12(7):764. doi: 10.3390/vaccines12070764.
5
Therapeutics of the future: Navigating the pitfalls of extracellular vesicles research from an osteoarthritis perspective.未来的治疗策略:从骨关节炎的角度来看待细胞外囊泡研究的陷阱。
J Extracell Vesicles. 2024 Jul;13(7):e12435. doi: 10.1002/jev2.12435.
6
Leveraging Senescent Cancer Cell Membrane to Potentiate Cancer Immunotherapy Through Biomimetic Nanovaccine.利用衰老癌细胞的细胞膜通过仿生纳米疫苗增强癌症免疫疗法。
Adv Sci (Weinh). 2024 Aug;11(30):e2400630. doi: 10.1002/advs.202400630. Epub 2024 Jun 12.
7
Polyethylene Glycol-Modified Cationic Liposome as a Promising Nano Spray for Acute Pneumonia Treatment.聚乙二醇修饰的阳离子脂质体作为一种有前景的纳米喷雾剂用于急性肺炎治疗。
Polymers (Basel). 2024 May 12;16(10):1384. doi: 10.3390/polym16101384.
8
Tea polyphenol-engineered hybrid cellular nanovesicles for cancer immunotherapy and androgen deprivation therapy.茶多酚工程化混合细胞纳米囊泡用于癌症免疫治疗和雄激素剥夺治疗。
J Nanobiotechnology. 2024 Apr 18;22(1):192. doi: 10.1186/s12951-024-02458-9.
9
Cell Membrane-Coated Nanoparticles for Precision Medicine: A Comprehensive Review of Coating Techniques for Tissue-Specific Therapeutics.细胞膜包覆纳米颗粒用于精准医学:组织特异性治疗的涂层技术全面综述。
Int J Mol Sci. 2024 Feb 8;25(4):2071. doi: 10.3390/ijms25042071.
10
Arsenic album 30C exhibits crystalline nano structure of arsenic trioxide and modulates innate immune markers in murine macrophage cell lines.砷酸钙 30C 呈现出三氧化二砷的纳米晶体结构,并调节了小鼠巨噬细胞系中的固有免疫标志物。
Sci Rep. 2024 Jan 7;14(1):745. doi: 10.1038/s41598-024-51319-w.
纳米技术在全球传染病中的应用。
Nat Nanotechnol. 2021 Apr;16(4):369-384. doi: 10.1038/s41565-021-00866-8. Epub 2021 Mar 22.
4
Novel approaches for vaccine development.新型疫苗研发方法。
Cell. 2021 Mar 18;184(6):1589-1603. doi: 10.1016/j.cell.2021.02.030.
5
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗策略:对3期候选疫苗的全面综述
NPJ Vaccines. 2021 Feb 22;6(1):28. doi: 10.1038/s41541-021-00292-w.
6
Non-depleting reformation of immunosuppressive myeloid cells to broaden the application of anti-PD therapy.免疫抑制性髓系细胞的非耗竭性重塑以拓宽抗PD疗法的应用范围
Nanoscale. 2021 Mar 4;13(8):4420-4431. doi: 10.1039/d1nr00830g.
7
A guide to vaccinology: from basic principles to new developments.疫苗学指南:从基本原则到新进展。
Nat Rev Immunol. 2021 Feb;21(2):83-100. doi: 10.1038/s41577-020-00479-7. Epub 2020 Dec 22.
8
DC-Based Vaccines for Cancer Immunotherapy.用于癌症免疫治疗的基于树突状细胞的疫苗
Vaccines (Basel). 2020 Nov 26;8(4):706. doi: 10.3390/vaccines8040706.
9
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.SARS-CoV-2 中和抗体 LY-CoV555 治疗门诊新冠患者的疗效。
N Engl J Med. 2021 Jan 21;384(3):229-237. doi: 10.1056/NEJMoa2029849. Epub 2020 Oct 28.
10
Activating Macrophage-Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles.通过基因编辑纳米颗粒激活巨噬细胞介导的癌症免疫疗法。
Adv Mater. 2020 Nov;32(47):e2004853. doi: 10.1002/adma.202004853. Epub 2020 Oct 21.